Physician profile
John Schmittner
NPI 1275891913
$9,869.37
in general payments reported to CMS, 2019-2025
19 companies · $320 in 2025
The $320 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,021 · 2020: $896 · 2021: $4,149 · 2022: $1,065 · 2023: $1,638 · 2024: $782 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,333 · Travel and Lodging: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,332.60 |
| Travel and Lodging | $407.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,325.43 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $1,571.72 | 2019-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $272.37 | 2021-2024 | Farxiga |
| Alnylam Pharmaceuticals INC. | $224.38 | 2022-2023 | Amvuttra |
| Merck Sharp & Dohme LLC | $204.68 | 2022-2023 | Verquvo |
| Pfizer INC. | $179.73 | 2021-2024 | |
| Actelion Pharmaceuticals US, INC. | $149.03 | 2020-2021 | |
| Cvrx, INC. | $123.77 | 2025 | Barostim Neo System |
| Endotronix, INC. | $122.30 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Medtronic, INC. | $113.34 | 2022 | |
| Novo Nordisk INC | $101.96 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.94 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $89.66 | 2024-2025 | Camzyos |
| United Therapeutics Corporation | $86.89 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $83.28 | 2021-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.95 | 2021-2023 | Lifevest |
| Scpharmaceuticals INC. | $29.60 | 2024 | |
| Akcea Therapeutics, INC. | $24.32 | 2021 | |
| Janssen Pharmaceuticals, INC | $22.02 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Schmittner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.